Spotify Premium Revenue Accelerates 15% YoY to €4.33B on Higher ARPU and Ad Recovery

What happened

Spotify's Q2'26 results, as reported by Zacks, show Premium revenue rising 15% year over year to €4.33 billion, driven by subscriber growth and higher average revenue per user (ARPU), while advertising revenue also posted gains. This marks a significant improvement from Q1'26, when Premium revenue was €4.148 billion and Ad-Supported revenue declined 5% year over year to €385 million. The improvement aligns with the key confirmation gates outlined in the DeepValue master report: Premium subscribers needed to meet or exceed 299 million and ad-supported revenue needed to return to positive growth, both of which appear to have been achieved. However, the report also highlighted persistent headwinds, including foreign exchange and product mix diluting ARPU (Q1'26 ARPU rose only 1% to €4.76 despite price increases) and ongoing litigation exposure of ~€358 million related to audiobook bundling. While the top-line acceleration is encouraging, investors should scrutinize the quality of the ad recovery (whether pricing stabilized or volume-driven) and whether ARPU growth is sustainable ex-FX.

Implication

If Q2'26 results confirm Premium subscriber growth above 299 million and ad-supported revenue returning to positive growth, the base case probability increases and the stock may re-rate toward the $470 implied value. However, the market may already be pricing in this recovery; at the current price (likely above $417.8), the risk/reward is less attractive because the stock is closer to the trim level of $520. The key variables to watch are whether the ad revenue gains are driven by pricing stabilization rather than just volume, and whether Premium ARPU growth is durable after accounting for FX and mix. Additionally, the audiobook litigation remains a potential overhang that could impair Premium economics if resolved adversely. A prudent approach is to hold existing positions, take profits above $520, and wait for a better entry near $380 if the stock pulls back on any guidance disappointment.

Thesis delta

The investment thesis shifts from a conditional WAIT to a more constructive stance as the two main confirmation gates (subscriber delivery and ad recovery) appear to have been met. The prior concern about ad-supported contraction is alleviated by reported gains, and Premium growth of 15% with higher ARPU suggests pricing power is translating into revenue, although FX/mix offsets remain to be verified. Consequently, the probability of the base case increases, but the stock's valuation may limit upside, so the rating could move to a speculative buy on dips rather than a neutral wait.